(Markman) Expert Says Biomarkers Top Priority for Immunotherapy Progress in Ovarian Cancer Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Wednesday, December 14, 2016

(Markman) Expert Says Biomarkers Top Priority for Immunotherapy Progress in Ovarian Cancer



http://www.onclive.com/web-exclusives/expert-says-biomarkers-top-priority-for-immunotherapy-progress-in-ovarian-cancer
 December 13, 2016

 In an interview with OncLive, Maurie Markman, president of Medicine and Science, Cancer Treatment Centers of America, discussed his presentation from the recent 2016 Chemotherapy Foundation Symposium (CFS), and comments on both recent advances and remaining challenges in the treatment of ovarian cancer....

... Only time will tell. But in my opinion, that’s what I would like to see in the next year—not another story of a 500-patient randomized phase III trial that is going to take 3 to 5 years to finish, maybe, if ever, and will show that there is minimal to no impact on an important clinical outcome.

0 comments :

Post a Comment

Your comments?